Table 6.
Results of including patients who are removed from the waiting list
| Results of exploratory analysis | |||||||
|---|---|---|---|---|---|---|---|
| Without EVLP | With EVLP | ||||||
| Survival after removal from waiting list | Cost | QALYs | Cost | QALYs | ICER | Cost source | QALY source |
| One month | £69,955 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | DEVELOP-UK [4] |
| £69,955 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | Anyanwu [14] | |
| £69,956 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | DEVELOP-UK [4] | |
| £69,956 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | Anyanwu [14] | |
| Three months | £69,958 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | DEVELOP-UK [4] |
| £69,958 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | Anyanwu [14] | |
| £69,959 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | DEVELOP-UK [4] | |
| £69,959 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | Anyanwu [14] | |
| Six months | £69,961 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | DEVELOP-UK [4] |
| £69,961 | 3.67 | £73,964 | 3.71 | £90,000 | Dzingina [28] | Anyanwu [14] | |
| £69,964 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | DEVELOP-UK [4] | |
| £69,964 | 3.67 | £73,964 | 3.71 | £90,000 | Georghiou [29] | Anyanwu [14] | |
| Parameters | |||||||
| Source | Disease area | Parameter type | Parameter value | ||||
| Dzingina 2017 | Advanced chronic disease | Palliative care cost per month | £1173 | ||||
| Georghiou 2014 | Any palliative care | Palliative care cost per month | £1644 | ||||
| DEVELOP-UK | Lung transplant | Quality adjusted life-years | 0.563 | ||||
| Anyanwu | Lung transplant | Quality adjusted life-years | 0.31 | ||||
*EVLP Ex-vivo lung perfusion, ICER Incremental cost-effectiveness ratio, QALYs Quality-adjusted life-years